ARATANA THERAPEUTICS, INC. Accretion Expense
ARATANA THERAPEUTICS, INC. reported Accretion Expense of $6.00 thousand for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2014-11-12
- ARATANA THERAPEUTICS, INC. accretion expense for the quarter ending 2014-09-30 was $6.00K, a 33.33% decline year-over-year.
- ARATANA THERAPEUTICS, INC. accretion expense for the quarter ending 2014-06-30 was $7.00K, a 16.67% increase year-over-year.
- ARATANA THERAPEUTICS, INC. accretion expense for the quarter ending 2014-03-31 was $9.00K, a 200.00% increase year-over-year.
- ARATANA THERAPEUTICS, INC. accretion expense for the quarter ending 2013-12-31 was $12.00K.
- ARATANA THERAPEUTICS, INC. accretion expense for fiscal 2013 was $33.00K.
| Period end | Accretion Expense 3 month | Accretion Expense 6 month | Accretion Expense 9 month | Accretion Expense 12 month |
|---|---|---|---|---|
| 2014-09-30 | $6.00K 10-Q · filed 2014-11-12 | $13.00K derived: sum of 2 quarters · filed 2014-11-12 | $21.00K 10-Q · filed 2014-11-12 | $34.00K derived: sum of 4 quarters · filed 2014-11-12 |
| 2014-06-30 | $7.00K 10-Q · filed 2014-08-13 | $15.00K 10-Q · filed 2014-08-13 | $28.00K derived: sum of 3 quarters · filed 2014-08-13 | $37.00K derived: sum of 4 quarters · filed 2014-08-13 |
| 2014-03-31 | $9.00K 10-Q · filed 2014-05-15 | $21.00K derived: sum of 2 quarters · filed 2014-05-15 | $30.00K derived: sum of 3 quarters · filed 2014-05-15 | $36.00K derived: sum of 4 quarters · filed 2014-08-13 |
| 2013-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | $21.00K derived: sum of 2 quarters · filed 2014-03-26 | $27.00K derived: sum of 3 quarters · filed 2014-08-13 | $33.00K 10-K · filed 2014-03-26 |
| 2013-09-30 | $9.00K 10-Q · filed 2013-11-14 | $15.00K derived: sum of 2 quarters · filed 2014-08-13 | $21.00K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $6.00K 10-Q · filed 2014-08-13 | $8.00K 10-Q · filed 2014-08-13 | ||
| 2013-03-31 | $3.00K 10-Q · filed 2014-05-15 |